Related Experiment Videos
Kinetics of G-quartet-mediated tetramer formation
J R Wyatt1, P W Davis, S M Freier
1ISIS Pharmaceuticals, Inc., Carlsbad, California 92008, USA.
Biochemistry
|June 18, 1996
Summary
Phosphorothioate oligodeoxynucleotides form stable tetramers that inhibit HIV. Their slow dissociation rate suggests potential for AIDS chemotherapy, despite thermodynamic instability.
Area of Science:
- Oligonucleotide chemistry
- Antiviral drug development
- Molecular biophysics
Background:
- Oligodeoxynucleotides, including phosphorothioate and phosphodiester variants, can form complex structures.
- The d(TTGGGGTT) sequence is known to form parallel-stranded tetramers stabilized by guanosine quartets.
- Phosphorothioate oligodeoxynucleotides have demonstrated in vitro inhibition of human immunodeficiency virus (HIV).
Purpose of the Study:
- To determine the kinetics of association and dissociation for phosphorothioate and phosphodiester d(TTGGGGTT) tetramers.
- To evaluate the stability and potential therapeutic applications of these tetramer structures, particularly for HIV/AIDS treatment.
Main Methods:
- Size exclusion chromatography was employed to measure the ratio of single strands to tetramers.
- Kinetic parameters (association and dissociation rates) were determined as a function of temperature.
- Thermodynamic properties, including energy of activation, were analyzed.
Main Results:
- The phosphorothioate tetramer exhibited a fourth-order association rate of 6.1 x 10(4) M-3 s-1 and a dissociation rate of 8.2 x 10(-6) min-1 at 37°C.
- The dissociation half-life (t1/2) for the phosphorothioate tetramer was approximately 60 days.
- The phosphodiester tetramer showed a faster association rate and a slower dissociation rate compared to the phosphorothioate variant.
- Both compounds displayed a negative energy of activation for the association reaction.
Conclusions:
- The phosphorothioate d(TTGGGGTT) tetramer forms a stable structure with an exceptionally slow dissociation rate.
- Despite thermodynamic instability at lower concentrations, the slow dissociation suggests potential utility in AIDS chemotherapy.
- Further investigation into the therapeutic efficacy of phosphorothioate tetramers is warranted.